MyAverix Finance
SHG · Healthcare
Shanghai Pharmaceuticals Holding Co Ltd (601607)
Medical Distribution
Shanghai Pharmaceuticals Holding Co Ltd (601607) is listed on SHG in the Healthcare sector. Industry: Medical Distribution. As of 2026-03-28, reported market cap is $61.89B, P/E ratio is 18.00, net margin is 2.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 601607
Shanghai Pharmaceuticals Holding Co Ltd (601607) — FAQ
What is Shanghai Pharmaceuticals Holding Co Ltd's market cap?
Shanghai Pharmaceuticals Holding Co Ltd (601607) has a reported market cap of $61.89B (data as of 2026-03-28).
What is 601607's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Pharmaceuticals Holding Co Ltd (601607) is 18.00 (data as of 2026-03-28).
Does Shanghai Pharmaceuticals Holding Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Pharmaceuticals Holding Co Ltd (601607). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Pharmaceuticals Holding Co Ltd in?
Shanghai Pharmaceuticals Holding Co Ltd (601607) is classified in the Healthcare sector (Medical Distribution industry).
What exchange is 601607 listed on?
601607 is listed on SHG.
What is Shanghai Pharmaceuticals Holding Co Ltd's net margin?
Shanghai Pharmaceuticals Holding Co Ltd (601607) reports a net margin of 2.0% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.